Global specialty chemicals company Lubrizol and fluid conveyance systems manufacturer Polyhose have inaugurated a new medical manufacturing facility in Chennai, marking a significant investment in India’s fast-growing medical technology sector.
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices, including critical neurovascular and cardiovascular applications. The investment is expected to strengthen local manufacturing capabilities while supporting growing demand from medical device makers in India and international markets.
Speaking at the inauguration, John Valukas, President, Lubrizol Engineered Materials, highlighted the strategic importance of the project.
“Today’s inauguration is an important milestone in Lubrizol’s commitment to India and to supporting our customers in the global medical device industry. By combining Lubrizol’s medical device expertise with the manufacturing strength of local partners in India, this facility will deliver advanced tubing solutions for life-saving neurovascular and cardiovascular applications.
"Our goal is to help our customers bring these critical technologies to patients faster, with reliable local supply and the highest quality standards.”
The Chennai facility has been established as an ISO13485-certified operation, providing customers with a dependable source of high-quality medical tubing supported by dedicated quality control systems and manufacturing standards aligned with Lubrizol’s global network.
The plant will manufacture precision extruded tubing using a range of high-performance materials, including polyamides, nylon, Pebax, polypropylene, polyethylene and Lubrizol’s medical-grade thermoplastic polyurethane (TPU).
The launch underscores Lubrizol’s broader strategy to deepen its presence in India, a market it views as a key driver of future growth.
“India is a strategic growth market for Lubrizol and a key hub for our investments in manufacturing, R&D and technical services. This medical manufacturing site in Chennai is another step in building a stronger local ecosystem for high-value, technology-driven products.
"By working closely with Polyhose and regional stakeholders, we aim to support innovation, create high-skilled jobs and enable India to become a more significant contributor to the global medical device supply chain,” said Abhishek Shrivastava, Managing Director, Lubrizol IMEA.
The facility is also expected to enhance access to advanced catheter tubing technologies for medical device manufacturers across India, the Middle East and Africa.
“Minimally invasive procedures are transforming patient care, and high-precision tubing is at the heart of many of these devices. With this Chennai site, we are bringing world-class catheter tubing capabilities closer to our customers in India and across IMEA.
"This partnership with Polyhose will enable a broad range of devices utilizing high-performance materials, further strengthening our ability to partner with medical device OEMs in India across the full product development lifecycle,” said Mittal Shah, Business Head, Medical Devices IMEA, Lubrizol.
For Polyhose, the collaboration represents a major step into the high-value medical devices segment, leveraging decades of manufacturing expertise.
“For more than three decades, Polyhose has partnered with global customers by delivering innovative extrusion and fluid conveyance solutions. Our collaboration with Lubrizol marks a new chapter in our journey, combining Polyhose's world-class manufacturing strengths with Lubrizol's deep materials science and medical device expertise to deliver advanced medical tubing solutions for the rapidly evolving healthcare industry.
"This investment reflects our commitment to innovation, creating skilled employment opportunities, and strengthening India's position as a trusted global hub for advanced medical device manufacturing,” said Shabbir Yusuf Jamnagarwala, Founder & Managing Director, Polyhose.
The new facility is expected to play a key role in expanding India’s footprint in the global medical device supply chain while accelerating the development and production of advanced technologies for minimally invasive healthcare solutions.
